Vaccine Development
CD40, B7, and major histocompatibility complex enhance immunity
Published in Vaccine Weekly, April 2nd, 2003
"Immunization of mice with activated antigen-presenting cells (APC) pulsed ex vivo with cryptococcal capsular polysaccharide, a glucuronoxylomannan (GXM-APC) results in prolongation of survival and delayed-type hypersensitivity (DTH) responsiveness following infection with Cryptococcus neoformans (NU-2)," researchers in the United States report.
"GXM-APC has both nonspecific and GXM-specific effects that influence the immune responses that develop in mice after infection with NU-2,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-04-02)
More Articles from Vaccine Weekly
- Pneumococcal Vaccine
23-Valent pneumococcal revaccination offers short-term protection for elderly - Vaccine Development
Promoter trap system increases expression of protective antigen - Cervical Cancer Vaccine
Dendritic cell vaccine shows promise against cervical cancer - Vaccine Development
New non-immunizing, paraspecific vaccines from attenuated pox viruses developed - Vaccine Development
Stabilization of dry powder vaccine formulations enhanced by rapid freezing - Vaccine Safety
Enterovirus induces antibody response with islet cell autoantigens in humans - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
